Clinical Trials Browser

INDUSTRY × emactuzumab × Tumor-Agnostic × Clear all

NCT03768063 2026-04-28

IMbrella B

Phase 3 Active not recruiting

Neoplasms

NCT02760797 2018-05-22

A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors

Phase 1 Completed

Neoplasms